Bortezomib

Catalog NumberPI390800881

CAS Number390800-88-1

CategoryAntineoplastic Agents

Bortezomib is the first drug of its type - a proteasome inhibitor. It is used for the treatment of multiple myeloma (MM), a blood cancer, and mantle cell lymphoma (MCL), a rare type of non-Hodgkin's lymphoma. In MM, its use includes retreatment for patients who had previously responded to treatment with bortezomib and relapsed at least six months after completing prior bortezomib treatment.